(Q46611118)

23 December 2017

title

Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum (English)

1 reference

23 December 2017

1 reference

8

Charles Levenback

1 reference

23 December 2017

Kathleen M. Schmeler

2

Kathleen M Schmeler

1 reference

23 December 2017

Pedro T. Ramirez

1

Pedro T Ramirez

1 reference

23 December 2017

David Gershenson

10

David M Gershenson

1 reference

23 December 2017

Brian Slomovitz

4

Brian M Slomovitz

1 reference

23 December 2017

author name string

Michael R Milam

3

1 reference

23 December 2017

Judith A Smith

5

1 reference

23 December 2017

John J Kavanagh

6

1 reference

23 December 2017

Michael Deavers

7

1 reference

23 December 2017

Robert L Coleman

9

1 reference

23 December 2017

language of work or name

English

0 references

publication date

5 May 2008

1 reference

23 December 2017

published in

Gynecologic Oncology

1 reference

23 December 2017

volume

110

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

56-59

1 reference

23 December 2017

Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.014

Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.014

Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.014

Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.014

Optimal two-stage designs for phase II clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.014

Hormonal therapy with letrozole for relapsed epithelial ovarian cancer. Long-term results of a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.014

Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.014

Is stabilization of disease a useful indicator for survival in second-line treatment of ovarian carcinoma pre-treated with Paclitaxel-Platinum?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.014

10.1016/J.YGYNO.2008.03.014

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017